SCHEMBL7425601

SCHEMBL7425601

CC(C)CC(C(=O)O)N(CCc1ccc(-c2ccc(F)cc2)cc1)C(=O)O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MCHR1 Q99705 2/20 0.50
MMP3 P08254 3/20 0.43
AOC3 Q16853 1/20 0.42
TAAR1 Q96RJ0 1/20 0.41
S1PR1 P21453 1/20 0.40
MMP2 P08253 2/20 0.39
FNTA P49354 1/20 0.39
PGGT1B P53609 1/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
GPR88 Q9GZN0 1/20 0.38
MME P08473 1/20 0.37
ACE P12821 1/20 0.37
HPGD P15428 1/20 0.37
TDP1 Q9NUW8 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
POLB P06746 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7426506 0.89 MMP2 (0.45) MCHR1AOC3TAAR1MMP2FNTA
SCHEMBL7424796 0.88 HPGD (0.38) MCHR1MMP3S1PR1MEN1KMT2A
SCHEMBL7420384 0.87 MMP12 (0.46) MCHR1GPR88CYP3A4CYP2D6CYP2C9
SCHEMBL7427409 0.87 MMP12 (0.46) MCHR1GPR88CYP3A4CYP2D6CYP2C9
SCHEMBL7418362 0.86 PSEN1 (0.51) MMP3MMP2
SCHEMBL7419478 0.84 MMP2 (0.42) MCHR1MMP3S1PR1MMP2MME
SCHEMBL7424015 0.84 GPR88 (0.42) MCHR1MMP2GPR88MME
SCHEMBL7417897 0.83 FOLH1 (0.45) MEN1KMT2AMMEACE
SCHEMBL7378945 0.83 MEN1 (0.48) MMP3AOC3TAAR1MMP2MEN1
SCHEMBL7429166 0.81 MMP2 (0.39) MMP2FNTAPGGT1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2002039997-A2 ACE-2 MODULATING COMPOUNDS AND USE THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2002-05-23 WO claimed
WO-2002039997-A2 ACE-2 MODULATING COMPOUNDS AND USE THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2002-05-23 WO disclosed